imatinib mesylate has been researched along with Infant, Newborn, Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, S; Fluchel, M; Hancock, J; Jacobsen, J; Salama, M | 1 |
1 other study(ies) available for imatinib mesylate and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib.
Topics: Antineoplastic Agents; Benzamides; Child, Preschool; Eosinophilia; Humans; Imatinib Mesylate; Infant, Newborn; Infant, Newborn, Diseases; Male; Myeloproliferative Disorders; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta | 2012 |